Biotechnology in Australia - Industry Risk Rating Report
INDUSTRY RISK RATINGS REPORT
This is the replacement for August 2009 edition of Biotechnology in Australia Industry Risk Ratings Report.
Industry Risk Ratings Synopsis
This Industry Risk Ratings report evaluates the inherent risks associated with the Biotechnology in Australia industry. Industry Risk is assumed to be 'the difficulty, or otherwise, of the business operating environment'.
The report looks at the operational risk associated with this industry. Three types of risk are recognized in our analysis. These are: risk arising from within the industry itself (structural risk), risks arising from the expected future performance of the industry (growth risk) and risk arising from forces external to the industry (external sensitivity risk).
This approach is new in that it analyses non-financial information surrounding each industry. Industries are scored on a 9-point scale, where 1 represents the lowest risk and 9 the highest. The Industry Risk score measures expected Industry Risk over the coming 12-18 months.
Industry Definition
Report Contents
Risk Overview
The Risk Overview chapter includes sections on Industry Definition and Activities, Industry Risk Score and Risk Rating Analysis. The Industry Definition and Activities section provides a detailed definition of the activities carried out by operators in this industry as defined in NAICS. A list of the primary activities of the industry is also included. The Industry Risk Score section provides the Overall Industry Risk Score as well as the Risk Scores for each of the three types of risk covered that combine to form the Overall Industry Risk Score. These three types of risk are Structural Risk, Growth Risk and External Sensitivity Risk. The Risk Rating Analysis section discusses the underlying factors contributing to the Overall Industry Risk Score.
Structural Risk
The Structural Risk chapter looks at risk arising from within the industry itself and provides a detailed discussion of the industry’s level of exposure to seven key indicators. These key indicators are Barriers to Entry, Competition, Industry Exports, Industry Imports, Level of Assistance, Life Cycle Stage and Volatility of Industry. The Overall Structural Risk Score is a weighted aggregation of these seven key indicators. Each of the key indicators is discussed in detail in this section.
Growth Risk
The Growth Risk chapter looks at risks arising from the expected future performance of the industry. The Overall Growth Risk Score is determined by amalgamating the scores for Recent Industry Growth and Forecast Industry Growth. Detailed analysis is provided discussing the reasons for the growth scores of both.
Sensitivity Risk
The Sensitivity Risk chapter looks at risks arising from forces (sensitivities) external to the industry. The Overall External Sensitivity Risk Score is determined by identifying the most significant (up to 6) external factors and weighting them to represent how significant each sensitivity is to the performance of the industry. Examples of External Sensitivities are Exchange Rates, Interest Rates, Commodity Prices and Government Regulations. There is also a detailed analysis of the affect each of the sensitivities has on the industry, including charts and data tables where appropriate.
Industry Risk and Industry Risk Scoring Methodology
This chapter provides an overview of how the author defines Industry Risk and discusses the methodology used to arrive at an Industry Risk Score. There is also a table that provides a definition of the seven levels of Industry Risk.
X0001 - Biotechnology in Australia
A - Agriculture, Forestry and Fishing in Australia
C2179 - Tea, Coffee and Other Food Manufacturing in Australia
C2543 - Pharmaceutical Product Manufacturing in Australia
O8622 - Specialist Medical Services in Australia
RELATED REPORTS
INDUSTRY RISK RATINGS REPORTThis is the replacement for March 2009 edition of Biotechnology in the US Industry Risk Ratings Report.Industry Risk Ratings SynopsisThis Industry Risk Ratings report evaluates the inherent risks associated with the Biotechnology in the US industry. Industry Risk is ass ...
Industries : Biotechnology
Datamonitor's Novo Nordisk A/S - SWOT Analysis company profile is the essential source for top-level company data and information. Novo Nordisk A/S - SWOT Analysis examines the company’s key business structure and operations, history and products, and provides summary analysis of its key revenue l ...
Industries : Biotechnology
Scope:‘Top 10 Global Biotechnology Companies Report: Strategic evaluation of industry and key players’ is a business report that provides a comprehensive view of the global biotechnology industry and its top 10 companies.The report includes the following:– Industry analysis including market va ...
Industries : Biotechnology
Product description The present Competitive Intelligence Report about VEGF and VEGF-R agonists and antagonists provides a competitor evaluation in the field of VEGF and its receptor targeting molecules for treatment of cancer, AMD and for neuroprotection as of September 2009. Purchase of the down ...
Industries : Biotechnology, Pharmaceutical
Product description The present Competitive Intelligence Report about Tumor Necrosis Factor (TNF) and TNF receptor antagonists and agonists used to treat TNF-mediated inflammatory diseases such as rheumatoid arthritis or to treat cancer, respectively, provides a competitor evaluation in the field o ...
Industries : Biotechnology, Pharmaceutical
The Biotechnology: Global Industry Guide is an essential resource for top-level data and analysis covering the Biotechnology industry. It includes detailed data on market size and segmentation, textual analysis of the key trends and competitive landscape, and profiles of the leading companies. This ...
Industries : Biotechnology
Despite their diversity, global healthcare systems are increasingly converging in the need and desire to contain costs of healthcare, and especially those associated with pharmaceuticals. At the same time, Big Pharma are having to contend with a dearth of invention, patent expirations, and increased ...
Industries : Biotechnology
Report DescriptionThe stem cell market is growing rapidly due to increasing regulatory approval and public acceptance bodies. The benefits of stem cell therapy are attracting an increasing number of patients. The product submarket for human and embryo stem cells are expected to drive the growth of t ...
Industries : Biotechnology, Pharmaceutical
Private Company Reports provide up to date insight into the structure and operations of privately-held pharmaceutical, biotechnology and biomedical companies.Scope of the report:Accessing accurate, current and comprehensive content on private companies can be challenging and Life Science Analytics h ...
Industries : Biotechnology, Pharmaceutical
Private Company Reports provide up to date insight into the structure and operations of privately-held pharmaceutical, biotechnology and biomedical companies.Scope of the report:Accessing accurate, current and comprehensive content on private companies can be challenging and Life Science Analytics h ...
Industries : Biotechnology, Pharmaceutical
Related industries
reportlinker.com © Copyright 2009. All rights reserved